MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/tid.70202

Медицинская библиотека · Transplant infectious disease : an official journal of the Transplantation Society · 2026

Comparative 3-Year Allograft Outcomes for Recipients of Kidneys From SARS-CoV-2 NAT-Positive Donors.

Koval Christine E, Eltemamy Mohamed, Shrestha Nabin K, Herlitz Leal, Poggio Emilio D, Wee Alvin C

СтатьяСравнительное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Data demonstrates safety and short-term success of kidney transplantation (KT) from SARS-CoV-2 NAT-positive organ donors (NAT+) compared to NAT-negative donors. However, detailed reports of longer-term graft outcomes are limited and lack granular data on donor SARS-CoV-2 infection severity.

METHODS

We retrospectively reviewed records from 220 recipients of KT (KTRs) at our institution from February 1, 2021, to January 31, 2022. We compared 1- and 3-year allograft-specific outcomes for KTRs from NAT+ (N = 59), CoV-COD (COVID as cause of death) (N = 56), and NAT-neg (N = 105) donors. We reviewed and compared pathology findings for allograft biopsies for all groups up to 1 year. We examined the association of eGFR at 3 years with CoV-donor status using multivariable linear regression.

RESULTS

At 1 year, there was no difference in rejection or kidney pathologies by CoV-donor status. At 3 years, there was no difference in patient death or graft loss by group. For subjects without graft loss, eGFR at 3 years for NAT+, CoV-COD, and NAT-neg donors was 54.8 (21.8), 45.6(17.9), and 48.4 (23.3) mL/min/m2, respectively (p = 0.61). On multivariable analysis, there was no significant association of eGFR with CoV-donor status.

CONCLUSIONS

We found no significant difference in pathological findings or 3-year allograft outcomes following KT from NAT-negative, NAT+, or CoV-COD donors. Despite modestly reduced eGFR for COV-COD on unadjusted analysis, kidneys from donors with a spectrum of COVID severities did not experience significantly poorer allograft outcomes over 3 years.

Для цитирования: Koval Christine E, Eltemamy Mohamed, Shrestha Nabin K, Herlitz Leal, Poggio Emilio D, Wee Alvin C. Comparative 3-Year Allograft Outcomes for Recipients of Kidneys From SARS-CoV-2 NAT-Positive Donors.. Transplant infectious disease : an official journal of the Transplantation Society. 2026. DOI: 10.1111/tid.70202.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.